BusinessImmune Design Announces Proposed Public Offering of Common StockBy Nasdaq OMXSep 14, 2016, 8:05 PM UTC
BusinessOrganovo and Collaborators Publish Data in Toxicological Sciences Demonstrating Power of 3D Bioprinted Human Liver Tissues in Modeling Drug-Induced Liver Injury Leading to FibrosisBy Nasdaq OMXSep 13, 2016, 12:05 PM UTC
BusinessArbutus’ Chief Scientific Officer, Dr. Michael J. Sofia, Awarded the 2016 Lasker~DeBakey Clinical Medical Research AwardBy Nasdaq OMXSep 13, 2016, 11:00 AM UTC
BusinessCytoDyn Announces $10.0 Million Registered Direct OfferingBy Nasdaq OMXSep 12, 2016, 1:11 PM UTC
BusinessGeron Provides Update on Imetelstat Trials Being Conducted by JanssenBy Nasdaq OMXSep 12, 2016, 11:30 AM UTC
BusinessAkari Therapeutics Announces Receipt of Orphan Drug Designation for Coversin from the U.S. FDA for Treatment of Paroxysmal Nocturnal HemoglobinuriaBy Nasdaq OMXSep 12, 2016, 11:15 AM UTC
BusinessTakeda and MacroGenics Announce the Conclusion of their MGD010 License and Option AgreementBy Nasdaq OMXSep 12, 2016, 11:00 AM UTC
BusinessCytokinetics Announces Additional Results From COSMIC-HF to Be Presented at the HFSA Annual Scientific MeetingBy Nasdaq OMXSep 9, 2016, 8:00 PM UTC
